Literature DB >> 19268743

Comparison of ventricular structure and function in Chinese patients with heart failure and ejection fractions >55% versus 40% to 55% versus <40%.

Kun-Lun He1, Daniel Burkhoff, Wen-Xiu Leng, Zhi-Ru Liang, Li Fan, Jie Wang, Mathew S Maurer.   

Abstract

Subjects with heart failure (HF) and a preserved ejection fraction (EF) are heterogenous and the EF used to define this syndrome varies considerably among studies. We sought to determine if physiologic differences exist between subjects with a normal EF (>55%) or mildly decreased EF (40% to 55%). 357 consecutive Chinese patients who were healthy (n = 93) or had HF (n = 264) underwent comprehensive echocardiography, Doppler analysis, and measurement of neurohormones. Subjects with HF were stratified by EF into those with normal EF (>55%, n = 128), mildly decreased EF (40% to 55%, n = 38), or moderate to severely decreased EF (<40%, n = 100). Employing noninvasive pressure-volume analysis, estimated end-systolic and end-diastolic pressure-volume relations were calculated. Subjects with HF and an EF 40% to 55% more often had a previous myocardial infarction and diabetes than those with HF and an EF >55%. Physiologically, the cohort with a mildly decreased EF had eccentrically enlarged ventricles with evidence of remodeling (rightward shifted end-diastolic pressure-volume relation) and decreased chamber contractility (downward shifted end-systolic pressure-volume relation) most comparable to subjects with overt systolic HF. In conclusion, in subjects with HF and a preserved EF, there are distinct physiologic differences between those with a normal (>55%) and a mildly decreased (40% to 55%) EF.

Entities:  

Mesh:

Year:  2009        PMID: 19268743      PMCID: PMC4940025          DOI: 10.1016/j.amjcard.2008.11.050

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  29 in total

1.  Usefulness of clinical variables, echocardiography, and levels of brain natriuretic peptide and norepinephrine to distinguish systolic and diastolic causes of acute heart failure.

Authors:  Craig S Vinch; Gerard P Aurigemma; Jeffrey C Hill; William H Gaasch; Gregory Volturo; Dennis A Tighe; Theo E Meyer
Journal:  Am J Cardiol       Date:  2003-05-01       Impact factor: 2.778

2.  Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study.

Authors:  S R Ommen; R A Nishimura; C P Appleton; F A Miller; J K Oh; M M Redfield; A J Tajik
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

Review 3.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

Review 4.  Diastolic heart failure: a separate disease or selection bias?

Authors:  Gilles W De Keulenaer; Dirk L Brutsaert
Journal:  Prog Cardiovasc Dis       Date:  2007 Jan-Feb       Impact factor: 8.194

5.  Effective arterial elastance as index of arterial vascular load in humans.

Authors:  R P Kelly; C T Ting; T M Yang; C P Liu; W L Maughan; M S Chang; D A Kass
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

6.  Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.

Authors:  Ali Ahmed; Michael W Rich; Jerome L Fleg; Michael R Zile; James B Young; Dalane W Kitzman; Thomas E Love; Wilbert S Aronow; Kirkwood F Adams; Mihai Gheorghiade
Journal:  Circulation       Date:  2006-07-24       Impact factor: 29.690

7.  Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.

Authors:  G M Felker; R E Thompson; J M Hare; R H Hruban; D E Clemetson; D L Howard; K L Baughman; E K Kasper
Journal:  N Engl J Med       Date:  2000-04-13       Impact factor: 91.245

Review 8.  Tissue Doppler imaging a new prognosticator for cardiovascular diseases.

Authors:  Cheuk-Man Yu; John E Sanderson; Thomas H Marwick; Jae K Oh
Journal:  J Am Coll Cardiol       Date:  2007-04-30       Impact factor: 24.094

9.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.

Authors:  Salim Yusuf; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

10.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.

Authors:  Walter J Paulus; Carsten Tschöpe; John E Sanderson; Cesare Rusconi; Frank A Flachskampf; Frank E Rademakers; Paolo Marino; Otto A Smiseth; Gilles De Keulenaer; Adelino F Leite-Moreira; Attila Borbély; István Edes; Martin Louis Handoko; Stephane Heymans; Natalia Pezzali; Burkert Pieske; Kenneth Dickstein; Alan G Fraser; Dirk L Brutsaert
Journal:  Eur Heart J       Date:  2007-04-11       Impact factor: 29.983

View more
  28 in total

1.  Heart failure with a normal ejection fraction: treatments for a complex syndrome?

Authors:  Samuel Bernard; Mathew S Maurer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

2.  Resveratrol enhanced FOXO3 phosphorylation via synergetic activation of SIRT1 and PI3K/Akt signaling to improve the effects of exercise in elderly rat hearts.

Authors:  Chih-Hsueh Lin; Cheng-Chieh Lin; Wei-Jen Ting; Pei-Ying Pai; Chia-Hua Kuo; Tsung-Jung Ho; Wei-Wen Kuo; Chung-Ho Chang; Chih-Yang Huang; Wan-Teng Lin
Journal:  Age (Dordr)       Date:  2014-08-27

3.  Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.

Authors:  Amil M Shah; Brian Claggett; Nancy K Sweitzer; Sanjiv J Shah; Inder S Anand; Eileen O'Meara; Akshay S Desai; John F Heitner; Guichu Li; James Fang; Jean Rouleau; Michael R Zile; Valetin Markov; Vyacheslav Ryabov; Gilmar Reis; Susan F Assmann; Sonja M McKinlay; Bertram Pitt; Marc A Pfeffer; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2014-08-13       Impact factor: 8.790

4.  Characterization of static and dynamic left ventricular diastolic function in patients with heart failure with a preserved ejection fraction.

Authors:  Anand Prasad; Jeffrey L Hastings; Shigeki Shibata; Zoran B Popovic; Armin Arbab-Zadeh; Paul S Bhella; Kazunobu Okazaki; Qi Fu; Martin Berk; Dean Palmer; Neil L Greenberg; Mario J Garcia; James D Thomas; Benjamin D Levine
Journal:  Circ Heart Fail       Date:  2010-08-03       Impact factor: 8.790

Review 5.  Echocardiographic assessment of pressure volume relations in heart failure and valvular heart disease: using imaging to understand physiology.

Authors:  P Green; S Kodali; M B Leon; M S Maurer
Journal:  Minerva Cardioangiol       Date:  2011-08       Impact factor: 1.347

6.  The impact of extra cardiac comorbidities on pressure volume relations in heart failure and preserved ejection fraction.

Authors:  Dmitry Abramov; Kun-Lun He; Jie Wang; Daniel Burkhoff; Mathew S Maurer
Journal:  J Card Fail       Date:  2011-05-06       Impact factor: 5.712

7.  Heart Failure with Mid-Range Ejection Fraction - a New Category of Heart Failure or Still a Gray Zone.

Authors:  Anca Andreea Andronic; Sorina Mihaila; Mircea Cinteza
Journal:  Maedica (Bucur)       Date:  2016-12

8.  Global Public Health Burden of Heart Failure.

Authors:  Gianluigi Savarese; Lars H Lund
Journal:  Card Fail Rev       Date:  2017-04

9.  Heart Failure with Preserved Ejection Fraction: Persistent Diagnosis, Therapeutic Enigma.

Authors:  Taslima Bhuiyan; Mathew S Maurer
Journal:  Curr Cardiovasc Risk Rep       Date:  2011-10

Review 10.  Ventricular remodeling in heart failure with preserved ejection fraction.

Authors:  Amil M Shah
Journal:  Curr Heart Fail Rep       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.